The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...
Both genetic factors and environmental influences, including infection with Epstein–Barr virus, contribute to multiple sclerosis susceptibility. The association between susceptibility to multiple ...